PROTABIT, LLC

PASADENA, CA · Biotech · Private

Engineered neutralizing antibodies against SARS-CoV-2 variants designed using AI/ML-guided protein engineering

Grants
$9.2M
13 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
5
1 granted · 4 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase II · STTR Phase II: Development of a computational protein engineering platform and its application to methane activating enzymes$750,000
Federal grantDepartment of Health and Human Services · Phase II · TriadWeb: An easy-to-use web-based platform for protein engineering$649,727
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase II · TriadWeb An easy to use web based platform for protein engineering$1,329,454
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase I · TriadWeb: An easy-to-use web-based platform for protein engineering.$799,727
Federal grantDepartment of Health and Human Services · Phase II · PEBank: A database for protein engineering data$219,294
Federal grantDepartment of Health and Human Services · Phase II · TriadWeb: An easy-to-use web-based platform for protein engineering$679,727
Federal grantDepartment of Health and Human Services · Phase II · PEBank: A database for protein engineering data$591,315
Federal grantDepartment of Health and Human Services · Phase II · PEBank: A database for protein engineering data$591,315
Federal grantDepartment of Health and Human Services · Phase II · Advancing Protein Engineering Using Artificial Intelligence and the ProtaBank Mutation Database$1,485,478
Federal grantNational Science Foundation · Phase I · STTR Phase I: COVID-19: AI-based Development of Neutralizing Antibodies for SARS-CoV-2$256,000
Federal grantDepartment of Health and Human Services · Phase II · Advancing Protein Engineering Using Artificial Intelligence and the ProtaBank Mutation Database$495,160
Federal grantNational Science Foundation · Phase II · STTR Phase II:Artificial Intelligence (AI)-based Development of Neutralizing Antibodies for SARS-CoV-2$1,000,000
Federal grantDepartment of Health and Human Services · Phase I · High-Throughput Engineering of Bispecific Antibodies$304,602
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1752Torque Medical Holdings, LLC—$4.7M
1753Navitor Pharmaceuticals—$65M
1754Aviceda Therapeutics—$99M
1755PROTABIT, LLC——
1756LAMNOTHERAPEUTICS, INC.——
1757REACTIVE BIOSCIENCES INC—$43M
1758Aerpio Therapeutics LLC—$45M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 5
  • Therapeutic Neutralizing Antibodies For SARS-COV-2application
  • Artificial Intelligence Platform For Protein Engineeringapplication
  • Engineered Recombinant Enzymes For Methane Oxidationgranted
  • Platform For Protein Storage, Analysis And Engineeringapplication
  • Engineered Recombinant Enzymes For Methane Oxidationapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.